Investors & Partners

NeoNeuro was established in June 2015 as a private French company by NeoVentures Biotechnology Inc. We have raised over 700.000 EUR to date to support our activities. We are currently seeking an additional 1.000.000 EUR to  assist us in moving through the diagnostic regulatory process and validation.

NeoNeuro is not a conventional start-up.The company is a subsidiary of NeoVentures Biotechnology and has access to considerable experience and proprietary platforms for the development of aptamer based solutions for Alzheimer’s diseases.The company was formed as a separate entity to enable equity investment to accelerate development.


bluedil logo1



aibl logo